<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2015-12-03" updated="2019-12-02">
  <drugbank-id primary="true">DB11326</drugbank-id>
  <name>Boric acid</name>
  <description>Boric acid, also known as hydrogen borate, is a weak monobasic Lewis acid of boron with the chemical formula H3BO3. Boric acid is typically utilized in industrial processing and manufacturing, but is also used as an additive in pharmaceutical products, cosmetics, lotions, soaps, mouthwash, toothpaste, astringents, and eyewashes [L2140]. It is known to exhibit some antibacterial activity against infections such as bacterial vaginosis and candidiasis [A32449].</description>
  <cas-number>10043-35-3</cas-number>
  <unii>R57ZHV85D4</unii>
  <average-mass>61.833</average-mass>
  <monoisotopic-mass>62.017524428</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A32449</ref-id>
        <pubmed-id>21774671</pubmed-id>
        <citation>Iavazzo C, Gkegkes ID, Zarkada IM, Falagas ME: Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence. J Womens Health (Larchmt). 2011 Aug;20(8):1245-55. doi: 10.1089/jwh.2010.2708. Epub 2011 Jul 20.</citation>
      </article>
      <article>
        <ref-id>A32450</ref-id>
        <pubmed-id>1432568</pubmed-id>
        <citation>Teshima D, Morishita K, Ueda Y, Futagami K, Higuchi S, Komoda T, Nanishi F, Taniyama T, Yoshitake J, Aoyama T: Clinical management of boric acid ingestion: pharmacokinetic assessment of efficacy of hemodialysis for treatment of acute boric acid poisoning. J Pharmacobiodyn. 1992 Jun;15(6):287-94.</citation>
      </article>
      <article>
        <ref-id>A32457</ref-id>
        <pubmed-id>19059942</pubmed-id>
        <citation>De Seta F, Schmidt M, Vu B, Essmann M, Larsen B: Antifungal mechanisms supporting boric acid therapy of Candida vaginitis. J Antimicrob Chemother. 2009 Feb;63(2):325-36. doi: 10.1093/jac/dkn486. Epub 2008 Dec 4.</citation>
      </article>
    </articles>
    <textbooks/>
    <links>
      <link>
        <ref-id>L2140</ref-id>
        <title>BORIC ACID - National Library of Medicine HSDB Database- Toxnet - NIH</title>
        <url>https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+1432</url>
      </link>
      <link>
        <ref-id>L2141</ref-id>
        <title>Boric Acid - National Toxicology Program - NIH</title>
        <url>https://ntp.niehs.nih.gov/ntp/htdocs/lt_rpts/tr324.pdf</url>
      </link>
    </links>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication>No FDA- or EMA-approved therapeutic indications on its own.</indication>
  <pharmacodynamics>Boric acid exhibits minimal bacteriostatic and antifungal activities [L2140]. Boric acid is likely to mediate antifungal actions at high concentrations over prolonged exposures [A32457]. </pharmacodynamics>
  <mechanism-of-action>Information regarding the mechanism of action of boric acid in mediating its antibacterial or antifungal actions is limited. Boric acid inhibits biofilm formation and hyphal transformation of _Candida albicans_, which are critical virulence factors [A32457]. In addition, arrest of fungal growth was observed with the treatment of boric acid [A32457].</mechanism-of-action>
  <toxicity>Acute oral LD50 is 2660 mg/kg in rat [MSDS]. Individuals are likely to be exposed to boric acid from industrial manufacturing or processing. Local tissue injury from boric acid exposure is likely due to caustic effects. Systemic effects from boric acid poisoning usually occur from multiple exposures over a period of days and involve gastrointestinal, dermal, CNS, and renal manifestations. Gastrointestinal toxicity include persistent nausea, vomiting, diarrhea, epigastric pain, hematemesis, and blue-green discoloration of the feces and vomit [L2140]. Following the onset of GI symptoms, a characteristic intense generalized erythroderma follows [L2140]. Management of mild to moderate toxicity should be supportive. In case of severe toxicity, dialysis may be required in addition to supportive treatment. </toxicity>
  <metabolism>No metabolic pathways reported. </metabolism>
  <absorption>Boric acid is well absorbed from the gastrointestinal tract, open wounds, and serous cavities but displays limited absorption in intact skin [L2140]. Following intraperitoneal injection in mice, the peak concentration was reached in about 1.0-1.5 hr in the brain whereas the value was 0.5 hr in other tissues [L2140]. </absorption>
  <half-life>According to human cases of poisoning, the elimination half-life of boric acid ranges from 13 to 24 hours [A32450, L2140].</half-life>
  <protein-binding>No protein binding reported. </protein-binding>
  <route-of-elimination>Regardless the route of administration, boric acid predominantly undergoes rapid renal excretion of &gt;90% of total administered dose as unchanged form. Small amounts are also excreted into sweat, saliva, and feces. Following administration as ointment, urinary excretion of boric acid accounted for only 1% of the administered dose [L2140].</route-of-elimination>
  <volume-of-distribution>Volume of distribution ranges from 0.17 to 0.5 L/kg in humans, where large amounts of boric acid are localized in brain, liver, and kidney [L2140].</volume-of-distribution>
  <clearance>A case report of acute boric acid poisoning following oral ingestion of 21 g of boric acid presents the total body clearance of 0.99 L/h before hemodialysis [A32450].</clearance>
  <classification>
    <description>This compound belongs to the class of inorganic compounds known as miscellaneous borates. These are inorganic compounds in which the largest metallic oxoanion is borate, to which either no atom or a non metal atom is bonded.</description>
    <direct-parent>Miscellaneous borates</direct-parent>
    <kingdom>Inorganic compounds</kingdom>
    <superclass>Mixed metal/non-metal compounds</superclass>
    <class>Miscellaneous mixed metal/non-metals</class>
    <subclass>Miscellaneous metallic oxoanionic compounds</subclass>
    <alternative-parent>Inorganic salts</alternative-parent>
    <alternative-parent>Metalloid salts</alternative-parent>
    <substituent>Borate</substituent>
    <substituent>Inorganic metalloid salt</substituent>
    <substituent>Inorganic salt</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="spanish" coder="">ácido bórico</synonym>
    <synonym language="english" coder="">boracic acid</synonym>
    <synonym language="english" coder="">hydrogen borate</synonym>
    <synonym language="english" coder="">orthoboric acid</synonym>
  </synonyms>
  <products>
    <product>
      <name>Acide Borique</name>
      <labeller>Produits Marc O (1987) Inc., Division Of Technilab Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00132624</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1951-12-31</started-marketing-on>
      <ended-marketing-on>2000-08-24</ended-marketing-on>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Boracic Acid Pwr</name>
      <labeller>Stanley Pharmaceuticals, A Division Of Vita Health Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00179043</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1972-12-31</started-marketing-on>
      <ended-marketing-on>2000-07-27</ended-marketing-on>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Boric Acid</name>
      <labeller>Dawson Traders Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00630373</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1985-12-31</started-marketing-on>
      <ended-marketing-on>2006-03-22</ended-marketing-on>
      <dosage-form>Powder, for solution</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Boric Acid Pwr 100%</name>
      <labeller>Regal Pharms, Division Of Bradcan Corporation</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00378224</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1978-12-31</started-marketing-on>
      <ended-marketing-on>1998-07-29</ended-marketing-on>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Nasal; Ophthalmic; Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Boric Acid Solution 2.5%</name>
      <labeller>Everest Pharmaceuticals Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00540994</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1982-12-31</started-marketing-on>
      <ended-marketing-on>1999-07-14</ended-marketing-on>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Ophthalmic</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>British Army Foot Pwr</name>
      <labeller>Regal Pharms, Division Of Bradcan Corporation</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00417033</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1980-12-31</started-marketing-on>
      <ended-marketing-on>2001-07-11</ended-marketing-on>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Collyre Hygienique Soker</name>
      <labeller>Produits Francais Labs Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00425745</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1978-12-31</started-marketing-on>
      <ended-marketing-on>1997-05-30</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Ophthalmic</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Eye Eze</name>
      <labeller>Pharmavite Laboratories (1987) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00581836</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1958-12-31</started-marketing-on>
      <ended-marketing-on>2006-07-27</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Ophthalmic</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Eye Wash 2.5%</name>
      <labeller>Canadian Custom Packaging Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00524468</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1983-12-31</started-marketing-on>
      <ended-marketing-on>2009-07-06</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Ophthalmic</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Eyewash</name>
      <labeller>Rivex Ophthalmics Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02212994</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-08-05</started-marketing-on>
      <ended-marketing-on>2000-08-03</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>1.2 %</strength>
      <route>Ophthalmic</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Gynox-soft</name>
      <labeller>Spai Sons Pharmaceutical International Cosmetics</labeller>
      <ndc-id/>
      <ndc-product-code>66854-003</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-06-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength>7 mg/100mL</strength>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Hemorro-dol Sup</name>
      <labeller>Produits Francais Labs Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00540919</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>1997-05-30</ended-marketing-on>
      <dosage-form>Suppository</dosage-form>
      <strength/>
      <route>Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>ICEKING Skin Expert Anti-onychomycosis Gel</name>
      <labeller>Shanghai Iceking Biotechnology Co.,Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code>72501-072</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-09-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Gel</dosage-form>
      <strength/>
      <route>Cutaneous; Infiltration</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Occu-cal Drops</name>
      <labeller>Produits Francais Labs Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00540935</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>1997-05-30</ended-marketing-on>
      <dosage-form>Solution / drops</dosage-form>
      <strength/>
      <route>Ophthalmic</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Occu-cal Lotion</name>
      <labeller>Produits Francais Labs Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00540927</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>1997-05-30</ended-marketing-on>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Ophthalmic</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>R.O.-eyewash</name>
      <labeller>Richmond Pharmaceuticals Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01943464</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1992-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-11</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Ophthalmic</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Recal D</name>
      <labeller>River's Edge Pharmaceuticals, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>68032-270</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-01-14</started-marketing-on>
      <ended-marketing-on>2012-10-31</ended-marketing-on>
      <dosage-form>Wafer</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>See Clean-One Eye Drops</name>
      <labeller>Cho-A Pharm.Co.,Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code>58354-105</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-12-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>21.644 mg/14mL</strength>
      <route>Ophthalmic</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sha-lem</name>
      <labeller>Shalem Products, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>59862-100</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1992-05-08</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Ointment</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Super Septic</name>
      <labeller>Ears R in Co Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00482153</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>1999-07-13</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Thunas Eye Drops</name>
      <labeller>Thuna Herbal Remedies Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00457345</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>2002-10-16</ended-marketing-on>
      <dosage-form>Solution / drops</dosage-form>
      <strength/>
      <route>Ophthalmic</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Trimo San Deodorant Vaginal Jelly</name>
      <labeller>Milex Products Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00484768</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>2005-07-25</ended-marketing-on>
      <dosage-form>Jelly</dosage-form>
      <strength/>
      <route>Vaginal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Recal D</name>
      <ingredients>Boric acid + Calcium carbonate + Cholecalciferol + Cyanocobalamin + Folic acid + Magnesium oxide + Pyridoxine</ingredients>
    </mixture>
    <mixture>
      <name>Gynox-soft</name>
      <ingredients>Boric acid</ingredients>
    </mixture>
    <mixture>
      <name>Sha-lem</name>
      <ingredients>Bismuth subcarbonate + Boric acid + Oleic Acid + Palmitic Acid + Stearic acid</ingredients>
    </mixture>
    <mixture>
      <name>See Clean-One Eye Drops</name>
      <ingredients>Boric acid</ingredients>
    </mixture>
    <mixture>
      <name>ICEKING Skin Expert Anti-onychomycosis Gel</name>
      <ingredients>Acetic acid + Boric acid</ingredients>
    </mixture>
    <mixture>
      <name>Boracic Acid Pwr</name>
      <ingredients>Boric acid</ingredients>
    </mixture>
    <mixture>
      <name>R.O.-eyewash</name>
      <ingredients>Boric acid</ingredients>
    </mixture>
    <mixture>
      <name>Acide Borique</name>
      <ingredients>Boric acid</ingredients>
    </mixture>
    <mixture>
      <name>Boric Acid Pwr 100%</name>
      <ingredients>Boric acid</ingredients>
    </mixture>
    <mixture>
      <name>Trimo San Deodorant Vaginal Jelly</name>
      <ingredients>Boric acid + Oxyquinoline + Sodium borate</ingredients>
    </mixture>
    <mixture>
      <name>Thunas Eye Drops</name>
      <ingredients>Boric acid + Sodium borate</ingredients>
    </mixture>
    <mixture>
      <name>Eyewash</name>
      <ingredients>Boric acid</ingredients>
    </mixture>
    <mixture>
      <name>British Army Foot Pwr</name>
      <ingredients>Boric acid + Formaldehyde + Salicylic acid + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Eye Wash 2.5%</name>
      <ingredients>Boric acid</ingredients>
    </mixture>
    <mixture>
      <name>Eye Eze</name>
      <ingredients>Boric acid + Sodium borate</ingredients>
    </mixture>
    <mixture>
      <name>Boric Acid</name>
      <ingredients>Boric acid</ingredients>
    </mixture>
    <mixture>
      <name>Collyre Hygienique Soker</name>
      <ingredients>Boric acid + Sodium borate</ingredients>
    </mixture>
    <mixture>
      <name>Super Septic</name>
      <ingredients>Boric acid + Ethanol</ingredients>
    </mixture>
    <mixture>
      <name>Hemorro-dol Sup</name>
      <ingredients>Balsam of Peru + Belladonna + Benzocaine + Bismuth subcarbonate + Bismuth subnitrate + Boric acid + Ephedrine + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Occu-cal Lotion</name>
      <ingredients>Boric acid + Phenylephrine + Sodium borate</ingredients>
    </mixture>
    <mixture>
      <name>Occu-cal Drops</name>
      <ingredients>Boric acid + Phenylephrine + Sodium borate</ingredients>
    </mixture>
    <mixture>
      <name>Boric Acid Solution 2.5%</name>
      <ingredients>Boric acid</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Acids</category>
      <mesh-id>D000143</mesh-id>
    </category>
    <category>
      <category>Acids, Noncarboxylic</category>
      <mesh-id>D000148</mesh-id>
    </category>
    <category>
      <category>Agrochemicals</category>
      <mesh-id>D016573</mesh-id>
    </category>
    <category>
      <category>Anti-Infective Agents</category>
      <mesh-id>D000890</mesh-id>
    </category>
    <category>
      <category>Boron Compounds</category>
      <mesh-id>D001896</mesh-id>
    </category>
    <category>
      <category>Compounds used in a research, industrial, or household setting</category>
      <mesh-id>D020313</mesh-id>
    </category>
    <category>
      <category>Insecticides</category>
      <mesh-id>D007306</mesh-id>
    </category>
    <category>
      <category>Otologicals</category>
      <mesh-id/>
    </category>
    <category>
      <category>Pesticides</category>
      <mesh-id>D010575</mesh-id>
    </category>
    <category>
      <category>Sensory Organs</category>
      <mesh-id/>
    </category>
    <category>
      <category>Toxic Actions</category>
      <mesh-id>D004786</mesh-id>
    </category>
  </categories>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Powder</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Powder, for solution</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Powder</form>
      <route>Nasal; Ophthalmic; Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Lotion</form>
      <route>Ophthalmic</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Powder</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Ophthalmic</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Ophthalmic</route>
      <strength>1.2 %</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Topical</route>
      <strength>7 mg/100mL</strength>
    </dosage>
    <dosage>
      <form>Suppository</form>
      <route>Rectal</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Gel</form>
      <route>Cutaneous; Infiltration</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Lotion</form>
      <route>Ophthalmic</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Ophthalmic</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Wafer</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Ophthalmic</route>
      <strength>21.644 mg/14mL</strength>
    </dosage>
    <dosage>
      <form>Ointment</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution / drops</form>
      <route>Ophthalmic</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Jelly</form>
      <route>Vaginal</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="S02AA03">
      <level code="S02AA">Antiinfectives</level>
      <level code="S02A">ANTIINFECTIVES</level>
      <level code="S02">OTOLOGICALS</level>
      <level code="S">SENSORY ORGANS</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes/>
  <pdb-entries>
    <pdb-entry>1a95</pdb-entry>
    <pdb-entry>1a96</pdb-entry>
    <pdb-entry>1a97</pdb-entry>
    <pdb-entry>1e3j</pdb-entry>
    <pdb-entry>1oj7</pdb-entry>
    <pdb-entry>1s3t</pdb-entry>
    <pdb-entry>2j9t</pdb-entry>
    <pdb-entry>2y8s</pdb-entry>
    <pdb-entry>2y8t</pdb-entry>
    <pdb-entry>3r2v</pdb-entry>
    <pdb-entry>3s42</pdb-entry>
    <pdb-entry>3v7n</pdb-entry>
    <pdb-entry>4ex6</pdb-entry>
    <pdb-entry>4ex7</pdb-entry>
    <pdb-entry>4k90</pdb-entry>
    <pdb-entry>4kyc</pdb-entry>
    <pdb-entry>5fsb</pdb-entry>
    <pdb-entry>5njw</pdb-entry>
    <pdb-entry>5wif</pdb-entry>
    <pdb-entry>5wmk</pdb-entry>
    <pdb-entry>6f9t</pdb-entry>
    <pdb-entry>6f9u</pdb-entry>
    <pdb-entry>6h5w</pdb-entry>
    <pdb-entry>6iwg</pdb-entry>
    <pdb-entry>6po4</pdb-entry>
    <pdb-entry>6qs1</pdb-entry>
  </pdb-entries>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB11326.pdf?1523054163</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-0.51</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>boric acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>boric acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>61.833</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>62.017524428</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>OB(O)O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>BH3O3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/BH3O3/c2-1(3)4/h2-4H</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>KGBXLFKZBHKPEV-UHFFFAOYSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>60.69</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>7.69</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>5.15</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>8.7</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>-5.3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>Soluble in hot water, partially soluble in cold water</value>
      <source>MSDS</source>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>169</value>
      <source>MSDS</source>
    </property>
    <property>
      <kind>Boiling Point</kind>
      <value>300</value>
      <source>MSDS</source>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>7148</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>6996</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>33118</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>7628</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>347827967</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C12486</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>7346</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>39817</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>BO3</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Boric_acid</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL42403</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>